EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹224 Cr | ₹227 Cr | ₹202 Cr | ₹178 Cr | ₹135 Cr |
What is the latest Total Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹224 Cr |
| Mar2024 | ₹227 Cr |
| Mar2023 | ₹202 Cr |
| Mar2022 | ₹178 Cr |
| Mar2021 | ₹135 Cr |
How is Total Liabilities of EVEREST ORGANICS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹224 Cr | -0.94 | |
| Mar2024 | ₹227 Cr | 12.27 | |
| Mar2023 | ₹202 Cr | 13.40 | |
| Mar2022 | ₹178 Cr | 31.48 | |
| Mar2021 | ₹135 Cr | - | |
Compare Total Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹322.8 Cr | 3.4% | 25.1% | -1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 3.4% |
25.1% |
-1.5% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses